Fundz

OverT Bio received $120,000 in a G-Rex Grant to advance its solid tumor cell therapy development, supported by ScaleReady and its partners.

PRIVATENov 22, 2024

Amount Raised

$120,000

Round Type

Pre-Seed

New YorkBiotechnology

Investors

CellReadyScaleReadyBio Techne CorporationWilson Wolf Manufacturing

Description

OverT Bio has been awarded a $120,000 G-Rex Grant to support its development of next-generation cell therapies for solid tumors. The grant is part of ScaleReady's $20 million program aimed at advancing cell and gene therapy manufacturing.

Quick answer

OverT Bio raised $120,000 in a Pre-Seed round, dated November 22, 2024. Investors: CellReady, ScaleReady, Bio Techne Corporation and Wilson Wolf Manufacturing. OverT Bio is based in New York, New York, United States.

How much did OverT Bio raise?
OverT Bio raised $120,000 in a Pre-Seed round on November 22, 2024.
Who invested in OverT Bio?
CellReady, ScaleReady, Bio Techne Corporation and Wilson Wolf Manufacturing are named as investors in this round.
What does OverT Bio do?
OverT Bio, Inc., is a New York based biotechnology company developing effective and safe cellular therapies for solid tumors.
Where is OverT Bio based and how big is it?
OverT Bio is based in New York, New York, United States.
Who are the decision-makers at OverT Bio?
Fundz holds 1 contact at OverT Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as OverT Bio that raised within 45 days of this round, from Fundz verified event records.

  • Agrobiomics raised $1.5M (Seed) on January 6, 2025.
  • Orbis Medicines raised $93M (Series A) on January 6, 2025.
  • Outset Medical raised $3.9M (Seed) on January 3, 2025.
  • General Proximity raised $16M (Seed) on January 3, 2025.
  • Botanic Healthcare raised $30M (Pre-Seed) on January 3, 2025.
  • Carna raised $3.4M (Seed) on January 3, 2025.

Who to call at OverT Bio, and when

A new round usually means OverT Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OverT Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OverT Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OverT Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OverT Bio

Location

430 E 29TH ST 14FL

New York, New York, United States

About

OverT Bio, Inc., is a New York based biotechnology company developing effective and safe cellular therapies for solid tumors. Harnessing innovative pooled functional screening and synthetic genomics platforms (OverTargetTM and OverTCRTM), OverT Bio is uncovering new therapeutic targets and genetic enhancements in an unbiased, data-driven manner to deliver breakthrough medicines to cancer patients underserved by the standard of care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OverT Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for OverT Bio's next move

See what Strategic adds

OverT Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.